• AI-10-49: A Selective CBFβ-SMMHC Inhibitor in AML Research

  2026-06-15

  AI-10-49 stands out as a powerful tool for dissecting the oncogenic CBFβ-SMMHC fusion axis in acute myeloid leukemia. Its specificity enables researchers to restore RUNX1 activity and interrogate the N-MYC/eIF4G1 pathway, accelerating both mechanistic and translational leukemia studies.

• 3-Methyladenine in Autophagy Research: Protocols & Innovatio

  2026-06-15

  3-Methyladenine (3-MA) is a cornerstone for dissecting autophagy and PI3K signaling in cancer and migration studies. This in-depth guide translates the latest mechanistic findings and reference-backed protocols into actionable workflows, with troubleshooting tips to maximize reproducibility and insight.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Applied Work

  2026-06-14

  The HyperScribe™ T7 High Yield Cy5 RNA Labeling Kit empowers researchers with flexible, high-yield fluorescent RNA probe synthesis for in situ hybridization and Northern blotting. Its customizable Cy5-UTP incorporation and robust workflow optimization unlock sensitive detection and reproducible results, even for demanding gene expression studies.

• Predicting Major Bleeding in Extended VTE Anticoagulation: N

  2026-06-13

  This article reviews recent advances in predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism (VTE). The referenced study introduces a new, simplified prediction tool (the CHAP model) and compares its performance with established risk scores, providing actionable guidance for clinical decision-making.

• Cy5.5 NHS Ester: Optimized Workflows for NIR Imaging & Conju

  2026-06-12

  Cy5.5 NHS ester (non-sulfonated) empowers high-sensitivity in vivo fluorescence imaging and robust protein conjugation, thanks to its near-infrared properties and stable amide bond formation. This article dives into experimental protocols, application-driven troubleshooting, and the translational impact of this dye in advanced neuromodulation and tumor optical imaging.

• InstaBlue Protein Stain Solution: Fast, Sensitive Protein De

  2026-06-12

  InstaBlue Protein Stain Solution streamlines protein visualization in polyacrylamide gels, enabling detection as low as 5 ng in only 5 minutes without fixation or destaining. Its compatibility with mass spectrometry and non-toxic, methanol-free formula set new standards for reliable, safe, and high-throughput protein electrophoresis analysis.

• EPZ-6438 (SKU A8221): Reliable EZH2 Inhibition for Epigeneti

  2026-06-11

  This article provides a scenario-driven, evidence-based exploration of EPZ-6438 (SKU A8221) as a selective EZH2 inhibitor for cell viability and epigenetic cancer research assays. Drawing from recent peer-reviewed data and practical lab challenges, it demonstrates how this compound from APExBIO delivers reproducible results and workflow advantages for biomedical researchers.

• Repurposing Natural Compounds Against SARS-CoV-2 Main Protea

  2026-06-11

  Eskandari et al. (2022) systematically evaluated natural vitamins for their potential to inhibit SARS-CoV-2 main protease (3CLpro) and the spike protein receptor-binding domain (RBD) using molecular docking and dynamics. Their findings highlight the promise of accessible, safe compounds for antiviral therapeutics research, offering new directions for COVID-19 intervention strategies.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Precision Pr

  2026-06-10

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit enables flexible, high-yield synthesis of fluorescent RNA probes for advanced gene expression and hybridization assays. Its tunable Cy5-UTP incorporation and robust T7 transcription workflow empower researchers to optimize probe sensitivity and specificity for applications such as in situ hybridization and Northern blotting.

• Targeting the CaN/FoxO1/FABP4 Pathway in Atherosclerosis Pro

  2026-06-10

  This study reveals that SERCA2 dysfunction accelerates atherosclerosis by activating the calcineurin/FoxO1/FABP4 pathway, promoting macrophage foam cell formation. Inhibiting FABP4 pharmacologically or genetically corrects lipid metabolism, suggesting new therapeutic avenues for atherosclerotic disease.

• Aconitase Activity: Illuminating TCA Cycle Insights in Immun

  2026-06-09

  Discover how precise measurement of iron-sulfur protein aconitase activity with the Aconitase Activity Colorimetric Assay Kit is reshaping translational research at the intersection of mitochondrial metabolism, oxidative stress, and immunometabolic reprogramming. This thought-leadership article bridges mechanistic insight and strategic guidance for scientists seeking robust biomarkers and workflow reliability in the era of metabolic precision medicine.

• Mannosylated Cholesterol LNPs Enhance In Vivo mRNA Delivery

  2026-06-09

  This study introduces cholesterol-derived mannosylated polypeptide-forming lipid nanoparticles (LNPs) that actively target antigen-presenting cells (APCs) for efficient in vivo mRNA delivery. The findings demonstrate improved lymph node accumulation and transfection in dendritic cells, presenting a promising strategy to boost mRNA vaccine efficacy while reducing required doses.

• FH1 Small Molecule: Redefining Hepatocyte Maturity for Trans

  2026-06-08

  Explore how FH1, a leading small molecule, revolutionizes cultured hepatocyte function enhancement and bridges optogenetic gene control with next-generation liver cell models. This article offers new insights beyond protocol optimization, focusing on practical implications for advanced translational research.

• Fangchinoline Restores Lysosomal Biogenesis to Block H1N1 En

  2026-06-08

  The reference study identifies fangchinoline as a potent activator of TFEB-driven lysosomal biogenesis, disrupting H1N1 influenza virus entry by restoring lysosomal function. These findings highlight a novel host-directed antiviral strategy and underscore the importance of targeting lysosomal pathways in infectious disease research.

• Myeloid Tet2-IL-1β Axis Restricts Stress-Driven Colitis via

  2026-06-07

  This study reveals how myeloid-specific loss of TET2 limits intestinal inflammation by increasing IL-1β, which dampens catecholaminergic neuron-epithelial crosstalk and reduces enterochromaffin cell differentiation. These findings uncover a neuro-immune-epithelial circuit that modulates colitis severity, highlighting the impact of stress and epigenetic regulation in gut immunity.

16458 records 1/1098 page Next 12345 下5页 Last page